EGRX Research and Charts

EGRX - Eagle Pharmaceuticals Inc (Healthcare: Drug Manufacturers - Specialty & Generic)

Projected Earnings Date: 2024-08-12 (Delayed quote data 2025-03-27)

Last 0.95	Change ⇓ -0.05 (-5.50%)	Volume 803
	Open 1.00	High 1.00	Low 0.89

8EMA (Daily) 1.18	40EMA (Daily) 1.14	50EMA (Daily) 1.12	STO (Daily) 68.261	MACD Hist (Daily) -0.089
8EMA (Weekly) 1.119	40EMA (Weekly) 2.41	50EMA (Weekly) 3.29	STO (Weekly) 74.065	MACD Hist (Weekly) 0.411


Company Profile
Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development, and under review for approval by the Food and Drug Administration.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.